Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/19/22 → 1/31/26 |
Funding
- Genentech, Inc (Agmt 01/19/22 AMD 4)
Prot #BN42358: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease
- Larson, Danielle Nicole (PD/PI)
Project: Research project